{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:58:45Z","timestamp":1762325925307},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijbiomac.2024.132200","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:54:26Z","timestamp":1715133266000},"page":"132200","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["A comprehensive review on targeting cluster of differentiation: An attractive strategy for inhibiting viruses through host proteins"],"prefix":"10.1016","volume":"269","author":[{"given":"Youle","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.132200_bb0005","unstructured":"WHO, Coronavirus (COVID-19) data, in: https:\/\/www.who.int\/data#reportsWorld, 2024 (Accessed February 27 2024)."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0020","unstructured":"WHO, Dengue and severe dengue, in: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue, 2024 (Accessed February 27 2024)."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0025","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/s41467-023-41017-y","article-title":"Projecting the future incidence and burden of dengue in Southeast Asia","volume":"14","author":"Col\u00f3n-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.15585\/mmwr.mm7230a3","article-title":"Travel-associated dengue cases - United States, 2010-2021","volume":"72","author":"Wong","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0035","unstructured":"WHO, HIV and AIDS, in: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids, 2024 (Accessed February 27 2024)."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro817","article-title":"Virus entry: molecular mechanisms and biomedical applications","volume":"2","author":"Dimitrov","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0966-842X(98)01263-3","article-title":"Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis","volume":"6","author":"Evans","year":"1998","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0050","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1002\/anie.202008835","article-title":"Molecular insights into small-molecule drug discovery for SARS-CoV-2","volume":"60","author":"Su","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tim.2017.10.004","article-title":"A tale of two viruses: does heterologous Flavivirus immunity enhance Zika disease?","volume":"26","author":"Sariol","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tips.2020.07.004","article-title":"Fruitful neutralizing antibody pipeline brings Hope to defeat SARS-Cov-2","volume":"41","author":"Renn","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0070","article-title":"Understanding antibody-dependent enhancement in dengue: are afucosylated IgG1s a concern?","volume":"19","author":"Teo","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0075","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cid\/ciad685","article-title":"Review: the landscape of antiviral therapy for COVID-19 in the era of widespread population immunity and omicron-lineage viruses","volume":"78","author":"Meyerowitz","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0080","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ymthe.2022.02.014","article-title":"The battle between host and SARS-CoV-2: innate immunity and viral evasion strategies","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol. Ther."},{"issue":"2015","key":"10.1016\/j.ijbiomac.2024.132200_bb0090","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.1502033","article-title":"Human leukocyte differentiation antigen workshops as a driving force in immunology","volume":"195","author":"Engel","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0095","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","article-title":"CD4 T-cell exhaustion: does it exist and what are its roles in Cancer?","volume":"27","author":"Miggelbrink","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2020.06.021","article-title":"CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling","volume":"182","author":"Oguri","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41467-023-35793-w","article-title":"CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer","volume":"14","author":"Houthuijzen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.123.323223","article-title":"CD147 Sparks atherosclerosis by driving M1 phenotype and impairing Efferocytosis","volume":"134","author":"Lv","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12352","article-title":"Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles","volume":"12","author":"Fan","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cell.2023.12.002","article-title":"Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques","volume":"187","author":"Saunders","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.2002.1624","article-title":"CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor","volume":"302","author":"Vermeire","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29512","article-title":"Design and synthesis of APN and 3CLpro dual-target inhibitors based on STSBPT with anticoronavirus activity","volume":"96","author":"Zheng","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nri2436","article-title":"Viral evasion and subversion of pattern-recognition receptor signalling","volume":"8","author":"Bowie","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0140","first-page":"232","article-title":"CARD8 kills CD4+ T cells in response to HIV entry","volume":"24","author":"Flemming","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/ciy1051","article-title":"Double-blinded, placebo-controlled trial of Sitagliptin for reducing inflammation and immune activation in treated and suppressed human immunodeficiency virus infection","volume":"69","author":"Dub\u00e9","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.946871","article-title":"CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation","volume":"13","author":"Qian","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0155","volume":"12","author":"Guti\u00e9rrez-Mart\u00ednez","year":"2023","journal-title":"Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells, eLife"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molmed.2007.11.001","article-title":"Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission","volume":"14","author":"de Witte","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0165","first-page":"1","article-title":"Li, CD36 is a co-receptor for hepatitis C virus E1 protein attachment","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0170","doi-asserted-by":"crossref","first-page":"14067","DOI":"10.1073\/pnas.0405695101","article-title":"L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus","volume":"101","author":"Cormier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2013.10.018","article-title":"Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization","volume":"101","author":"Deest","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41392-022-01230-5","article-title":"CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011860","article-title":"The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin \u237a4\u03b27","volume":"19","author":"Van Ryk","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0396","article-title":"Microsecond dynamics control the HIV-1 envelope conformation","volume":"10","author":"Bennett","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.176.2.507","article-title":"The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure","volume":"176","author":"Moebius","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0200","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/jvi.64.12.5701-5707.1990","article-title":"Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding","volume":"64","author":"Olshevsky","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0205","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/ar4002735","article-title":"Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist","volume":"47","author":"Courter","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0804-9","article-title":"Structural basis of coreceptor recognition by HIV-1 envelope spike","volume":"565","author":"Shaik","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0215","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1073\/pnas.87.2.748","article-title":"Isolation of a new herpesvirus from human CD4+ T cells","volume":"87","author":"Frenkel","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0220","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.91.9.3872","article-title":"CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus","volume":"91","author":"Lusso","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0225","first-page":"2381","volume":"76","author":"Yasukawa","year":"1995","journal-title":"CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.healun.2023.08.014","article-title":"Favorable effect of CD26\/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis","volume":"43","author":"Yamada","year":"2024","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0235","doi-asserted-by":"crossref","unstructured":"Y. Iwamoto, T. Kimura, K. Dan, H. Iwamoto, J. Sanada, Y. Fushimi, Y. Katakura, M. Shimoda, Y. Nogami, Y. Shirakiya, S. Nakanishi, T. Mune, K. Kaku, H. Kaneto, Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice, diabetes Obes. Metab. (2024) Online ahead of print, DOI: https:\/\/doi.org\/10.1111\/dom.15548.","DOI":"10.1111\/dom.15548"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0240","doi-asserted-by":"crossref","DOI":"10.34133\/2020\/2402961","article-title":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis","volume":"2020","author":"Wang","year":"2020","journal-title":"Research"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108824","article-title":"Systemic DPP4\/CD26 is associated with natural HIV-1 control: implications for COVID-19 susceptibility","volume":"230","author":"Govender","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg","volume":"9","author":"Vankadari","year":"2020","journal-title":"Microbes Infect."},{"issue":"2020","key":"10.1016\/j.ijbiomac.2024.132200_bb0265","first-page":"613","article-title":"Novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"W. Tai, L. He, X. Zhang, J. Pu, D. Voronin, S. Jiang, Y. Zhou, L. Du, Characterization of the receptor-binding domain (RBD) of","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0270","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0275","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","article-title":"Myeloid C-type lectin receptors in innate immune recognition","volume":"57","author":"Reis","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1074-7613(02)00259-5","article-title":"DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection","volume":"16","author":"Kwon","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0295","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.biomaterials.2014.01.014","article-title":"A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and dengue virus","volume":"35","author":"Varga","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0300","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2017.00314","article-title":"Host immune responses in HIV-1 infection: the emerging pathogenic role of Siglecs and their clinical correlates","volume":"8","author":"Mikulak","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0305","article-title":"Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides","volume":"10","author":"Izquierdo-Useros","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0310","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41564-019-0453-2","article-title":"Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry","volume":"4","author":"Perez-Zsolt","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0315","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/all.14429","article-title":"Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors","volume":"75","author":"Radzikowska","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0320","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0330","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1073\/pnas.111583198","article-title":"CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A","volume":"98","author":"Pushkarsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0335","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/JVI.02168-09","article-title":"CD147\/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells","volume":"84","author":"Watanabe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0340","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-017-01706-x","article-title":"Receptor-binding loops in alphacoronavirus adaptation and evolution","volume":"8","author":"Wong","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0345","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01118-21","article-title":"Roles of two major domains of the porcine Deltacoronavirus S1 subunit in receptor binding and neutralization","volume":"95","author":"Liu","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0350","doi-asserted-by":"crossref","first-page":"9606","DOI":"10.1128\/JVI.00559-12","article-title":"Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81","volume":"86","author":"Rajesh","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0355","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jac\/dki208","article-title":"Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs","volume":"56","author":"Vermeire","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115816","article-title":"Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds","volume":"28","author":"Lumangtad","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/17460441.2012.643865","article-title":"Improving potencies and properties of CD4 down-modulating CADA analogs","volume":"7","author":"Bell","year":"2012","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0370","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.63.1.203","article-title":"The anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor","volume":"63","author":"Vermeire","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0375","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/jm0582524","article-title":"Synthesis and structure\u2212activity relationship studies of CD4 Down-modulating Cyclotriazadisulfonamide (CADA) analogues","volume":"49","author":"Bell","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0380","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/JVI.79.10.6122-6133.2005","article-title":"Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0385","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/molecules23113036","article-title":"Virtual screening, biological evaluation, and 3D-QSAR studies of new HIV-1 entry inhibitors that function via the CD4 primary receptor","volume":"23","author":"Zhang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0390","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1021\/acs.jafc.3c09529","article-title":"Quinolizidine alkaloids and Isoflavones from the herb of Thermopsis lupinoides and their antiviral, antifungal, and insecticidal activities","volume":"72","author":"Zhang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0395","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/acs.jafc.4c00992","article-title":"Aloperine-type alkaloids with antiviral and antifungal activities from the seeds of Sophora alopecuroides L","volume":"72","author":"Hu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0091-6749(03)02007-4","article-title":"Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding","volume":"112","author":"Kawai","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0405","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2008.12.024","article-title":"Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy","volume":"123","author":"Nance","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2011.10.001","article-title":"Green tea EGCG, T cells, and T cell-mediated autoimmune diseases","volume":"33","author":"Wu","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012168","article-title":"Palmitic acid analogs exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar inhibition of gp120-to-CD4 fusion","volume":"5","author":"Paskaleva","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0420","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.molimm.2006.04.018","article-title":"Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1","volume":"44","author":"Xiao","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0425","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1021\/acs.jmedchem.6b00475","article-title":"Comparative analysis of binding kinetics and thermodynamics of dipeptidyl Peptidase-4 inhibitors and their relationship to structure","volume":"59","author":"Schnapp","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0430","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1128\/JVI.76.24.12855-12865.2002","article-title":"Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding","volume":"76","author":"Hong","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s42003-022-03090-9","article-title":"Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay","volume":"5","author":"Narayanan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0440","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0445","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41426-018-0068-3","article-title":"Contribution of porcine aminopeptidase N to porcine deltacoronavirus infection","volume":"7","author":"Zhu","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0450","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0455","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/med.20044","article-title":"Aminopeptidase-N\/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects","volume":"26","author":"Bauvois","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0460","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/1062936X.2020.1734080","article-title":"Exploring the structural aspects of ureido-amino acid-based APN inhibitors: a validated comparative multi-QSAR modelling study","volume":"31","author":"Banerjee","year":"2020","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0465","first-page":"52","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite","volume":"13","author":"Wilson","year":"2015","journal-title":"Plasmodium falciparum, BMC Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112739","article-title":"Azithromycin: the first broad-spectrum therapeutic","volume":"207","author":"Firth","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0480","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0485","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-3542(99)00031-5","article-title":"De Clercq, selective activity of various antiviral compounds against HHV-7 infection","volume":"43","author":"Zhang","year":"1999","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0490","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0006-291X(89)92828-3","article-title":"Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes","volume":"158","author":"Kawaguchi","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0495","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1074\/jbc.M114.627026","article-title":"CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding","volume":"290","author":"Jay","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0500","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1099\/jgv.0.000432","article-title":"Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81","volume":"97","author":"Qian","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0505","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejmech.2011.01.022","article-title":"Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists","volume":"46","author":"Wang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.gastro.2012.03.036","article-title":"A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes","volume":"143","author":"Haid","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection","volume":"7","author":"He","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0520","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12985-020-01361-7","article-title":"Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells","volume":"17","author":"Huang","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0525","doi-asserted-by":"crossref","first-page":"21595","DOI":"10.1038\/s41598-022-26206-x","article-title":"Brazilin from Caesalpinia sappan inhibits viral infection against PRRSV via CD163(\u0394SRCR5) MARC-145 cells: an in silico and in vitro studies","volume":"12","author":"Arjin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0530","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/bc2000403","article-title":"Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection","volume":"22","author":"Luczkowiak","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0535","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1073\/pnas.0404006101","article-title":"Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor","volume":"101","author":"de Parseval","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0540","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nsmb872","article-title":"Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus","volume":"12","author":"de Parseval","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0545","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1092124","article-title":"Use of CD134 as a primary receptor by the feline immunodeficiency virus","volume":"303","author":"Shimojima","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0550","doi-asserted-by":"crossref","first-page":"19980","DOI":"10.1073\/pnas.0911307106","article-title":"Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134","volume":"106","author":"Grant","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0555","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1073\/pnas.1305187110","article-title":"CD134 is a cellular receptor specific for human herpesvirus-6B entry","volume":"110","author":"Tang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0560","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.1128\/JVI.01606-15","article-title":"Determinants of human CD134 essential for entry of human herpesvirus 6B","volume":"89","author":"Tang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0565","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1021\/acs.bioconjchem.9b00066","article-title":"Unprecedented Thiacalixarene Fucoclusters as strong inhibitors of Ebola cis-cell infection and HCMV-gB glycoprotein\/DC-SIGN C-type lectin interaction","volume":"30","author":"Taouai","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0570","doi-asserted-by":"crossref","first-page":"14332","DOI":"10.1021\/acs.jmedchem.1c00818","article-title":"Low-valent calix[4]arene Glycoconjugates based on Hydroxamic acid bearing linkers as potent inhibitors in a model of Ebola virus Cis-infection and HCMV-gB-recombinant glycoprotein interaction with MDDC cells by blocking DC-SIGN","volume":"64","author":"Chakroun","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0575","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.antiviral.2012.10.007","article-title":"Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection","volume":"96","author":"Alen","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0580","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.tim.2017.06.001","article-title":"Antiviral strategies against PRRSV infection","volume":"25","author":"Du","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0585","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1128\/JVI.01893-13","article-title":"Role of DC-SIGN in Lassa virus entry into human dendritic cells","volume":"87","author":"Goncalves","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0590","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1128\/JVI.01094-08","article-title":"Utilization of DC-SIGN for entry of feline coronaviruses into host cells","volume":"82","author":"Regan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0595","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0600","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1039\/C2SC00767C","article-title":"Quinoxalinone inhibitors of the lectin DC-SIGN","volume":"3","author":"Mangold","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0605","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M504337200","article-title":"Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals","volume":"280","author":"Lozach","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0610","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0966-842X(00)88972-6","article-title":"CD46-mediated measles virus entry: a first key to host-range specificity","volume":"3","author":"Gerlier","year":"1995","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0615","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00826-21","article-title":"Ex vivo and in vivo CD46 receptor utilization by species D human adenovirus serotype 26 (HAdV26)","volume":"96","author":"Hemsath","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0620","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1128\/JVI.77.8.4992-4999.2003","article-title":"Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46","volume":"77","author":"Mori","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0625","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1128\/JVI.78.4.1792-1799.2004","article-title":"CD46 is a cellular receptor for bovine viral diarrhea virus","volume":"78","author":"Maurer","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0630","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1128\/JVI.80.8.3912-3922.2006","article-title":"Function of bovine CD46 as a cellular receptor for bovine viral diarrhea virus is determined by complement control protein 1","volume":"80","author":"Krey","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0635","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1073\/pnas.92.6.2303","article-title":"Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46)","volume":"92","author":"Manchester","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0640","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2327385","article-title":"Porcine low-density lipoprotein receptor plays an important role in classical swine fever virus infection","volume":"13","author":"Leveringhaus","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0645","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(82)90239-2","article-title":"Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts","volume":"30","author":"Thorley-Lawson","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0650","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0655","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0660","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/JVI.75.13.5842-5850.2001","article-title":"Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors","volume":"75","author":"Tatsuo","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0665","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/prot.26595","article-title":"SLAM (CD150) receptor homologous peptides block the peste des petits ruminants virus entry into B95a cells","volume":"92","author":"Agrawal","year":"2024","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0670","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10930-023-10134-4","article-title":"Development of hemagglutinin-neuraminidase homologous peptides as novel promising therapeutic agents against Peste des Petits ruminants virus","volume":"42","author":"Agrawal","year":"2023","journal-title":"Protein J."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0675","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41564-023-01383-1","article-title":"Age-associated features of norovirus infection analysed in mice","volume":"8","author":"Kennedy","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008242","article-title":"CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus","volume":"16","author":"Graziano","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0685","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01663-23","article-title":"Human norovirus cultivation systems and their use in antiviral research","volume":"98","author":"Hayashi","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0690","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/emboj\/21.9.2076","article-title":"Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family","volume":"21","author":"Tan","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0695","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/JVI.78.1.216-223.2004","article-title":"N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein","volume":"78","author":"Miura","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0700","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.7150\/thno.83405","article-title":"The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0705","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0807848105","article-title":"Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0710","volume":"13","author":"Saito","year":"2021","journal-title":"Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus, mBio"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0715","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/1078-0432.CCR-0690-3","article-title":"Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21","volume":"10","author":"Shafren","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0720","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.1123016","article-title":"Origins of HIV and the evolution of resistance to AIDS","volume":"313","author":"Heeney","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0725","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1073\/pnas.1821197116","article-title":"CD4 receptor diversity in chimpanzees protects against SIV infection","volume":"116","author":"Bibollet-Ruche","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0730","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1462-5822.2004.00480.x","article-title":"Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation","volume":"7","author":"Koppel","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0735","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nri1182","article-title":"DC-SIGN: escape mechanism for pathogens","volume":"3","author":"van Kooyk","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0740","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1039\/D0CS01118E","article-title":"Antiviral drug discovery: preparing for the next pandemic","volume":"50","author":"Adamson","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0745","volume":"9","author":"Xu","year":"2020","journal-title":"CD163 and pAPN double-knockout pigs are resistant to PRRSV and TGEV and exhibit decreased susceptibility to PDCoV while maintaining normal production performance, eLife"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0750","first-page":"e01906","article-title":"Characterization of gut microbiota compositions along the intestinal tract in CD163\/pAPN double knockout piglets and their potential roles in Iron absorption","author":"Zhang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0755","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejmech.2017.07.048","article-title":"Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies","volume":"139","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037633","article-title":"CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis","volume":"7","author":"Geloen","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0765","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/jm2002603","article-title":"Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents","volume":"54","author":"Demillo","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002011","article-title":"Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation","volume":"12","author":"Vermeire","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0775","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/jp0550762","article-title":"How can (\u2212)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors","volume":"110","author":"Hamza","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0780","first-page":"1220","article-title":"C16 saturated fatty acid induced autophagy in A549 cells through topoisomerase I inhibition","volume":"3","author":"Karna","year":"2012","journal-title":"Food Nutr. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0785","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.1128\/JVI.79.21.13519-13527.2005","article-title":"Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer","volume":"79","author":"Turville","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0790","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1172\/JCI25105","article-title":"Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes","volume":"115","author":"Naarding","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0795","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nsmb784","article-title":"Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR","volume":"11","author":"Guo","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0800","article-title":"Cryptotanshinone protects porcine alveolar macrophages from infection with porcine reproductive and respiratory syndrome virus","volume":"104937","author":"Huang","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0805","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/med.21763","article-title":"Drug repurposing approach to combating coronavirus: potential drugs and drug targets","volume":"41","author":"Xu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0810","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2014.06.044","article-title":"Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin","volume":"83","author":"Lai","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111966","article-title":"Kidney injury in COVID-19 patients, drug development and their renal complications: review study","volume":"142","author":"Mohamadi Yarijani","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0820","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3324\/haematol.2018.199661","article-title":"The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells","volume":"104","author":"Spinello","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0825","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1074-5521(03)00169-8","article-title":"Irreversible inhibition of CD13\/aminopeptidase N by the antiangiogenic agent curcumin","volume":"10","author":"Shim","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0830","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0835","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.chom.2017.10.002","article-title":"NRP2 and CD63 are host factors for Lujo virus cell entry","volume":"22","author":"Raaben","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0840","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1099\/0022-1317-79-6-1387","article-title":"Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N","volume":"79","author":"Hegyi","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0845","volume":"95","author":"Cagatay","year":"2021","journal-title":"Porcine complement regulatory protein CD46 is a major receptor for atypical porcine pestivirus but not for classical swine fever virus"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0850","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/JVI.01849-15","article-title":"The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection","volume":"90","author":"Carnec","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0855","volume":"94","author":"Smith","year":"2020","journal-title":"CD21 (Complement Receptor 2) is the receptor for Epstein-Barr virus entry into T cells"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0860","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human complement receptor type 1\/CD35 is an Epstein-Barr virus receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0865","volume":"9","author":"Vanarsdall","year":"2018","journal-title":"CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells, mBio"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0870","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01557-21","article-title":"CD46 isoforms influence the mode of entry by human herpesvirus 6A\/B in T cells","volume":"96","author":"Rossen","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008648","article-title":"Structural basis for the interaction of human herpesvirus 6B tetrameric glycoprotein complex with the cellular receptor, human CD134","volume":"16","author":"Nishimura","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0880","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0885","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1128\/JVI.75.4.1594-1600.2001","article-title":"V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor","volume":"75","author":"Ono","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0890","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1128\/JVI.00649-14","article-title":"Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q","volume":"88","author":"von Kietzell","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0895","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/JVI.75.5.2444-2451.2001","article-title":"Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1","volume":"75","author":"Xiao","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0900","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-020-0615-9","article-title":"Cellular receptors for enterovirus A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0905","doi-asserted-by":"crossref","first-page":"15547","DOI":"10.1074\/jbc.M113.473298","article-title":"Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages","volume":"288","author":"Kuda","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.132200_bb0910","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.77.8.4827-4835.2003","article-title":"Complexes of poliovirus serotypes with their common cellular receptor, CD155","volume":"77","author":"He","year":"2003","journal-title":"J. Virol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024030058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024030058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:40:06Z","timestamp":1719920406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024030058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":182,"alternative-id":["S0141813024030058"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132200","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on targeting cluster of differentiation: An attractive strategy for inhibiting viruses through host proteins","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"132200"}}